XRCC1 and urinary bladder cancer: In XRCC1 rs1799782, compared to the GG genotype, AA genotype was associated with an increased risk of bladder cancer (P = 0.005, adjusted OR = 2.67, 95% CI: 1.35–5.26), and this SNP was also associated with an increased risk under recessive model (AA vs. GG + GA, P = 0.001, adjusted OR = 2.91, 95% CI: 1.51–5.61).